NovoCure (NVCR) Receivables (2014 - 2026)
NovoCure (NVCR) posted Receivables of $106.8 million for Q2 2026, up 5.2% sequentially from $101.5 million in Q1 2026, and up 10.26% YoY from $96.9 million in Q2 2025.
NovoCure (NVCR) Receivables (2014 - 2026) Analysis & Trends
NovoCure has reported Receivables for 13 years, with the latest figure at $106.8 million in Q2 2026.
- Quarterly Receivables rose 10.26% year-over-year to $106.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $106.8 million (up 10.26% YoY) and the FY2025 annual result came in at $97.2 million, up 21.6% from the prior year.
- Receivables grew to $106.8 million in Q2 2026 per NVCR's latest filing, from $101.5 million in the prior quarter.
- Over five years, Receivables peaked at $106.8 million in Q2 2026 and troughed at $26.9 million in Q4 2023.
- A 5-year average of $78.9 million and a median of $81.2 million in 2022 frame the typical range for Receivables.
- The sharpest annual moves came in 2022 and 2023: Receivables soared 419.55% in 2022, then tumbled 69.56% in 2023.
- Over 5 years, Receivables stood at $88.5 million in 2022, then sank by 69.56% to $26.9 million in 2023, then jumped by 51.47% to $40.8 million in 2024, then soared by 62.93% to $66.5 million in 2025, then surged by 60.71% to $106.8 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $106.8 million, $101.5 million, and $66.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.01 Bn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | 106.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.80 Mn |
| Mar 31, 2026 | 101.52 Mn |
| Dec 31, 2025 | 66.46 Mn |
| Sep 30, 2025 | 92.48 Mn |
| Jun 30, 2025 | 96.86 Mn |
| Mar 31, 2025 | 91.07 Mn |
| Dec 31, 2024 | 40.79 Mn |
| Sep 30, 2024 | 72.80 Mn |
| Jun 30, 2024 | 69.54 Mn |
| Mar 31, 2024 | 69.78 Mn |
| Dec 31, 2023 | 26.93 Mn |
| Sep 30, 2023 | 65.13 Mn |
| Jun 30, 2023 | 70.99 Mn |
| Mar 31, 2023 | 74.83 Mn |
| Dec 31, 2022 | 88.45 Mn |
| Sep 30, 2022 | 87.55 Mn |
| Jun 30, 2022 | 97.56 Mn |
| Mar 31, 2022 | 100.97 Mn |
| Dec 31, 2021 | 17.03 Mn |
| Sep 30, 2021 | 94.13 Mn |